VRTX · Vertex Pharmaceuticals Inc / Ma

$547.38 +0.09 (+0.02%) At close · Aug 27

Market Cap

$138.72B

253.46M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-04	2026-06-30
8-K	2026-08-03	—
8-K	2026-07-07	2026-07-06
Investor Event Transcript	2026-07-06	2026-09-30
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-10	2026-06-30
Investor Event Transcript	2026-05-29	2026-06-30
8-K	2026-05-13	—
10-Q	2026-05-05	2026-03-31
8-K	2026-05-04	—
8-K	2026-04-29	2026-04-28
DEF 14A	2026-04-02	2026-05-13
Investor Event Transcript	2026-03-31	—
8-K	2026-03-31	—
Investor Event Transcript	2026-03-31	—
10-K	2026-02-13	2025-12-31
8-K	2026-02-12	—
10-Q	2025-11-04	2025-09-30
8-K	2025-11-03	—
10-Q	2025-08-05	2025-06-30
8-K	2025-08-04	—
8-K	2025-05-19	—
8-K	2025-05-14	—
10-Q	2025-05-06	2025-03-31
8-K	2025-05-05	—
DEF 14A	2025-04-03	2025-05-14
8-K	2025-03-28	—
10-K	2025-02-13	2024-12-31
8-K	2025-02-10	2025-02-04
8-K	2024-12-20	—
10-Q	2024-11-05	2024-09-30
8-K	2024-11-04	—
8-K	2024-08-16	2024-08-15
10-Q	2024-08-02	2024-06-30
8-K	2024-08-01	—
8-K	2024-06-27	—
8-K	2024-05-20	—
8-K	2024-05-15	—
10-Q	2024-05-07	2024-03-31
8-K	2024-05-06	—
8-K	2024-04-11	2024-04-10
DEF 14A	2024-04-04	2023-05-15
10-K	2024-02-15	2023-12-31
8-K	2024-02-05	—
8-K	2023-12-08	—
8-K	2023-12-05	—
10-Q	2023-11-07	2023-09-30
8-K	2023-11-06	—
8-K	2023-10-05	2023-10-03
10-Q	2023-08-02	2023-06-30

Showing 1–50 of 95 filings

Key facts CIK 875320 CUSIP 92532F100 13F (30d) 1175 filings 1158 filers Visit website Investor relations